Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sex difference in circulating PCSK9 and its clinical implications
Fang Jia, Si-Fan Fei, Debing Tong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22

Showing 22 citing articles:

Targeting PCSK9 to tackle cardiovascular disease
Sandra Hummelgaard, Joachim Vilstrup, Camilla Gustafsen, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108480-108480
Open Access | Times Cited: 52
Sex differences in efficacy and safety of PCSK9 monoclonal antibodies: A real-world registry
Annette M.H. Galema‐Boers, Janneke W.C.M. Mulder, Kim Steward, et al.
Atherosclerosis (2023) Vol. 384, pp. 117108-117108
Open Access | Times Cited: 18
Italian Association of Hospital Cardiologists Position Paper ‘Gender discrepancy: time to implement gender-based clinical management’
Fabiana Lucà, Daniela Pavan, Michele Massimo Gulizia, et al.
European Heart Journal Supplements (2024) Vol. 26, Iss. Supplement_2, pp. ii264-ii293
Open Access | Times Cited: 6
Sex Differences in Familial Hypercholesterolemia
Marianne Klevmoen, Janneke W.C.M. Mulder, Jeanine E. Roeters van Lennep, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 11, pp. 861-868
Open Access | Times Cited: 16
Sex Differences in Therapies against Myocardial Ischemia-Reperfusion Injury: From Basic Science to Clinical Perspectives
Lejla Medzikovic, Tara Azem, Wasila Sun, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2077-2077
Open Access | Times Cited: 13
Antipsychotic-Induced Alterations in Lipid Turnover
Sandra Pereira, Emily Au, Sri Mahavir Agarwal, et al.
Endocrinology (2023) Vol. 164, Iss. 4
Open Access | Times Cited: 12
Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review
Jakub Michał Zimodro, M Mucha, Heiner K. Berthold, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 913-913
Open Access | Times Cited: 4
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women
Julie A E van Oortmerssen, Janneke W. C. M. Mulder, Marte F. van der Bijl, et al.
Current Atherosclerosis Reports (2025) Vol. 27, Iss. 1
Open Access
Lipid metabolism in women: A review
Julie A E van Oortmerssen, Janneke W.C.M. Mulder, Maryam Kavousi, et al.
Atherosclerosis (2025) Vol. 405, pp. 119213-119213
Open Access
Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention
Michelangelo Rottura, María Antonietta Barbieri, Carmine Siniscalchi, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19
Patricia Mester, Pablo Amend, Stephan Schmid, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1511-1511
Open Access | Times Cited: 9
Sex X Time Interactions in Lp(a) and LDL-C Response to Evolocumab
Federica Fogacci, Serra İlayda Yerlitaş, Marina Giovannini, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3271-3271
Open Access | Times Cited: 8
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patients
Claudia Torino, Federico Carbone, Patrizia Pizzini, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 9
Closed Access | Times Cited: 2
Sex aspects in lipoprotein metabolism, dyslipidemia, and lipid-lowering therapy: A comprehensive review
Jakub Michał Zimodro, M Mucha, Heiner K. Berthold, et al.
(2024)
Open Access | Times Cited: 2
Monoclonal Anti-PCSK9 Antibodies: Real-World Data
Giulia Guidotti, Viola Liberati, A. Sorrentino, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4543-4543
Open Access | Times Cited: 2
Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis
Janne Pott, Azin Kheirkhah, Jesper R. Gådin, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Predictive factors for multivessel disease in patients with acute coronary syndrome: analysis from the CCC-ACS project in China
Houlin He, Jun Wang, Yasong Wang, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes
Anna Licata, Giuseppina Russo, Annalisa Giandalia, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 558-558
Open Access | Times Cited: 3
Insight into the role of PCSK9 in glucose metabolism
Jia-ni Xu, Tingting Wang, Hong Shu, et al.
Clinica Chimica Acta (2023) Vol. 547, pp. 117444-117444
Open Access | Times Cited: 2
Sex Differences in Pharmacokinetics, Pharmacodynamics, and Adverse Drug Reactions of Cardiovascular Drugs
Amanda Evelo, Emiel Leegwater, Loes E. Visser
(2024), pp. 445-459
Closed Access
Sex differences in LDL‐C reduction response to evolocumab: A propensity score matching analysis
Yun He, Yuqing Wei, Huang Guang-ming, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2024) Vol. 44, Iss. 11, pp. 861-869
Closed Access
Mechanisms underlying the effects of the conditional knockdown of hepatic PCSK9 in attenuating lipopolysaccharide-induced acute liver inflammation
Miao Miao, Xueying Zhang, Haiyan Yu, et al.
International Journal of Biological Macromolecules (2024), pp. 139066-139066
Closed Access
Page 1

Scroll to top